Cutler Group LP Clovis Oncology, Inc. Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$1.05 - $2.85 $12,075 - $32,775	-11,500 Reduced 39.25%	17,800 $30,000
Q2 2022 Aug 04, 2022	SELL	$0.63 - $2.96 $5,103 - $23,976	-8,100 Reduced 21.66%	29,300 $42,000
Q1 2022 Apr 14, 2022	BUY	$1.43 - $3.14 $53,482 - $117,436	37,400 New	37,400 $94,000
Q2 2021 Jul 19, 2021	SELL	$5.02 - $7.05 $501 - $705	-100 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$4.13 - $6.41 $21,889 - $33,973	-5,300 Reduced 98.15%	100 $0
Q3 2020 Oct 27, 2020	BUY	$4.82 - $7.72 $25,546 - $40,916	5,300 Added 5300.0%	5,400 $3,000
Q2 2020 Jul 22, 2020	SELL	$5.69 - $9.69 $2,845 - $4,845	-500 Reduced 83.33%	100 $0
Q1 2020 May 07, 2020	SELL	$3.77 - $11.0 $11,310 - $33,000	-3,000 Reduced 83.33%	600 $11,000
Q4 2019 Feb 06, 2020	SELL	$3.0 - $16.43 $78,000 - $427,180	-26,000 Reduced 87.84%	3,600 $21,000
Q4 2018 Feb 05, 2019	BUY	$11.63 - $32.67 $197,710 - $555,390	17,000 Added 134.92%	29,600 $56,000
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $11,748 - $19,792	-400 Reduced 3.08%	12,600 $176,000
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $307,038 - $455,520	-7,300 Reduced 35.96%	13,000 $82,000
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $2.52 Million - $3.4 Million	-50,200 Reduced 71.21%	20,300 $83,000
Q4 2017 Jan 17, 2018	SELL	$57.69 - $84.58 $1.37 Million - $2.01 Million	-23,800 Reduced 25.24%	70,500 $115,000
Q3 2017 Oct 17, 2017	BUY	$67.17 - $84.81 $6.33 Million - $8 Million	94,300	94,300 $102,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.